Indication
Critically Ill
8 clinical trials
9 products
2 drugs
Clinical trial
A Phase II Open Label Randomised Controlled Clinical Trial of Different Dosing Regimens of Fludrocortisone in Septic Shock With Assessment of Temporal Changes in Hormonal, Inflammatory, and Genetic Markers of Vascular ResponsivenessStatus: Completed, Estimated PCD: 2023-04-30
Product
FludrocortisoneClinical trial
Course of Inflammation and Infection Markers in Critically Ill ICU Patients Under Casirivimab- and/or Tocilizumab ApplicationStatus: Completed, Estimated PCD: 2022-04-28
Product
Treated withoutClinical trial
Evaluation of Glomerular Filtration Rate Using Iohexol Plasma Clearance in Critically Ill Patients With Augmented Renal Creatinine ClearanceStatus: Recruiting, Estimated PCD: 2024-03-01
Product
IohexolClinical trial
Efficacy of Ketamine-fentanyl VS Fentanyl for Analgosedation in Postoperative Ventilated SICU PatientsStatus: Active (not recruiting), Estimated PCD: 2021-12-30
Drug
KetamineProduct
Normal salineClinical trial
Targeted Perfusion Based Haemodynamic Management in Critically Ill Patients Using Urethral Perfusion - a Pilot StudyStatus: Recruiting, Estimated PCD: 2024-06-01
Product
NaClClinical trial
Clinically Integrated Opportunistic PK/PD Trial in Critically Ill ChildrenStatus: Recruiting, Estimated PCD: 2024-09-30
Product
OPTIC studyClinical trial
Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation - A Prospective, Randomized, Controlled, Open, Cross-over, Phase II, Single-center Pilot Study [BiPhox-Trial]Status: Completed, Estimated PCD: 2023-11-15
Product
CVVH with PhoxiliumProduct
CVVH with BiphozylClinical trial
Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Sepsis: A Feasibility Study for a Multicenter Double-Blind Randomized Placebo-Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2027-02-28
Product
EmpagliflozinDrug
Varlilumab